Activation of PPARγ by rosiglitazone attenuates intestinal Cl - secretion

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 297, Issue 1, 2009, Pages

  Bajwa, Poonam J ^a   Lee, Jimmy W ^a   Straus, Daniel S ^a   Lytle, Christian ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antidiarrheal; HT29 cells; KCa3.1; Kv7.1; KvLQT1; KCNE3; KCNN4; KCNQ1; MiRP2; Mouse intestine; Pioglitazone; Rosiglitazone; Secretory diarrhea

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM ACTIVATED POTASSIUM CHANNEL 3.1; CALCIUM ION; CHLORIDE ION; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; POTASSIUM CHANNEL KCNQ1; ROSIGLITAZONE; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; SODIUM POTASSIUM CHLORIDE COTRANSPORTER 1; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG; 2,4 THIAZOLIDINEDIONE DERIVATIVE; CALCIUM; CARBACHOL; CFTR PROTEIN, HUMAN; CHLORIDE; CHOLERA TOXIN; CYCLIC AMP; FORSKOLIN; GASTROINTESTINAL AGENT; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; KCNN4 PROTEIN, HUMAN; KCNQ1 PROTEIN, HUMAN; SODIUM POTASSIUM CHLORIDE COTRANSPORTER 1 PROTEIN; SODIUM-POTASSIUM-CHLORIDE COTRANSPORTER 1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN HT29; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; CHEMICALLY INDUCED DISORDER; COLON; DIARRHEA; DISEASE MODEL; DRUG POTENTIATION; ILEUM; IMPEDANCE; INTESTINE; INTESTINE SECRETION; JEJUNUM; METABOLISM; ORAL DRUG ADMINISTRATION; TIME;

ADMINISTRATION, ORAL; ANIMALS; CALCIUM; CARBACHOL; CHLORIDES; CHOLERA TOXIN; COLON; CYCLIC AMP; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DIARRHEA; DISEASE MODELS, ANIMAL; ELECTRIC IMPEDANCE; FEMALE; FORSKOLIN; GASTROINTESTINAL AGENTS; HT29 CELLS; HUMANS; ILEUM; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; INTESTINAL SECRETIONS; INTESTINES; JEJUNUM; KCNQ1 POTASSIUM CHANNEL; MICE; PPAR GAMMA; SODIUM-POTASSIUM-CHLORIDE SYMPORTERS; THIAZOLIDINEDIONES; TIME FACTORS;

EID: 67650096546     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.90640.2008     Document Type: Article

References (53)

1. Adachi M, Kurotani R, Morimura K, Shah Y, Sanford M, Madison BB, Gumucio DL, Marin HE, Peters JM, Young HA, Gonzalez FJ. Peroxisome proliferator activated receptor-γ in colonic epithelial cells protects against experimental inflammatory bowel disease. Gut 55: 1104-1113, 2006.
2. + channels. Am J Physiol Gastrointest Liver Physiol 293: G1288-G1299, 2007.
3. Banwell JG, Pierce NF, Mitra RC, Brinham KL, Caranasos GJ, Keimowitz RI, Fedson DS, Thomas J, Gorbach SL, Sack RB, Mondal A. Intestinal fluid and electrolyte transport in human cholera. J Clin Invest 49: 183-195, 1970.
4. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, Evans RM. PPARγ is required for placental, cardiac, and adipose tissue development. Mol Cell 4: 585-595, 1999.
5. Barrett KE. Positive and negative regulation of chloride secretion in T84 cells. Am J Physiol Cell Physiol 265: C859-C868, 1993.
6. Bassaganya-Riera J, Reynolds K, Martino-Catt S, Cui Y, Hennighausen L, Gonzalez FJ, Rohrer J, Benninghoff A, Hontecillas R. Activation of PPARγ and by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology 127: 777-791, 2004.
7. Bohme M, Diener M, Rummel W. Calcium- and cyclic-AMP-mediated secretory responses in isolated colonic crypts. Pflügers Arch 419: 144-151, 1991.
8. Broughman JR, Sun L, Umar S, Scott J, Sellin JH, Morris AP. Chronic PKC-β activation in HT-29 Cl.19a colonocytes prevents cAMP-mediated ion secretion by inhibiting apical membrane current generation. Am J Physiol Gastrointest Liver Physiol 291: G318-G330, 2006.
9. Bull AW, Steffensen KR, Leers J, Rafter JJ. Activation of PPARγ in colon tumor cell lines by oxidized metabolites of linoleic acid, endogenous ligands for PPARγ. Carcinogenesis 24: 1717-1722, 2003.
10. Chen L, Bush CR, Necela BM, Su W, Yanagisawa M, Anastasiadis PZ, Fields AP, Thompson EA. RS5444, a novel PPARγ agonist, regulates aspects of the differentiated phenotype in nontransformed intestinal epithelial cells. Mol Cell Endocrinol 251: 17-32, 2006.
11. Chen L, Yang B, McNulty JA, Clifton LG, Binz JG, Grimes AM, Strum JC, Harrington WW, Chen Z, Balon TW, Stimpson SA, Brown KK. GI262570, a peroxisome proliferator-activated receptor γ agonist, changes electrolytes and water reabsorption from the distal nephron in rats. J Pharmacol Exp Ther 312: 718-725, 2005.
12. Cuthbert AW, MacVinish LJ, Hickman ME, Ratcliff R, Colledge WH, Evans MJ. Ion-transporting activity in the murine colonic epithelium of normal animals and animals with cystic fibrosis. Pflügers Arch 428: 508-515, 1994.
13. Doucet L, Mendes F, Montier T, Delepine P, Penque D, Ferec C, Amaral MD. Applicability of different antibodies for the immunohistochemical localization of CFTR in respiratory and intestinal tissues of human and murine origin. J Histochem Cytochem 51: 1191-1199, 2003.
14. Drori S, Girnun GD, Tou L, Szwaya JD, Mueller E, Kia X, Shivdasani RA, Spiegelman BM. Hic-5 regulates an epithelial program mediated by PPARγ. Genes Dev 19: 362-375, 2005.
15. + channel Kcnn4. J Physiol 583: 705-717, 2007.
16. Fryer LGD, Parbu-Patel A, Carling D. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 277: 25226-25232, 2002.
17. Gabriel SE, Davenport SE, Steagall RJ, Vimal V, Carlson T, Rozhon EJ. A novel plant-derived inhibitor of cAMP-mediated fluid and chloride secretion. Am J Physiol Gastrointest Liver Physiol 276: G58-G63, 1999.
18. Gordon JI. Intestinal epithelial differentiation: new insights from chimeric and transgenic mice. J Cell Biol 108: 1187-1194, 1989.
19. Grubb BR, Lee E, Pace AJ, Koller BH, Boucher RC. Intestinal ion transport in NKCC1-deficient mice. Am J Physiol Gastrointest Liver Physiol 279: G707-G718, 2000.
20. Guan Y, Hao C, Cha DR, Rao R, Lu W, Kohan DE, Magnuson MA, Redha R, Zhang Y, Breyer MD. Thiazolidinediones expand body fluid volume through PPARγ stimulation of ENaC-mediated renal salt absorption. Nat Med 11: 861-866, 2005.
21. Gupta RA, Brockman JA, Sarraf P, Willson TM, DuBois RN. Target genes of peroxisome proliferator-activated receptor γ in colorectal cancer cells. J Biol Chem 276: 29681-29687, 2001.
22. Hallows KR, Kobinger GP, Wilson JM, Witters LA, Foskett JK. Physiological modulation of CFTR activity by AMP-activated protein kinase in polarized T84 cells. Am J Physiol Cell Physiol 284: C1297-C1308, 2003.
23. Heitzmann D, Warth R. Physiology and pathophysiology of potassium channels in gastrointestinal epithelia. Physiol Rev 88: 1119-1182, 2008.
24. + T cell-mediated protection against colitis. J Immunol 178: 2940-2949, 2007.
25. Jay RT, Talmage B, Emily H, Alan SV. Prevention of toxin-induced intestinal ion and fluid secretion by a small-molecule CFTR inhibitor. Gastroenterology 126: 511-519, 2004.
26. Kazufumi K, Koichiro W, Atsushi N, Hiroyuki M, Takao H, Shinsaku N, Takashi K, Ryozo N, Yoshinori K, Richard SB, Tadanori M. A novel PPARγ gene therapy to control inflammation associated with inflammatory bowel disease in a murine model. Gastroenterology 124: 1315-1324, 2003.
27. Kirk KL, Dawson DC. Basolateral potassium channel in turtle colon. Evidence for single-file ion flow. J Gen Physiol 82: 297-329, 1983.
28. Kunzelmann K, Mall M. Electrolyte transport in the mammalian colon: mechanisms and implications for disease. Physiol Rev 82: 245-289, 2002.
29. Laplante M, Festuccia WT, Soucy G, Gelinas Y, Lalonde J, Deshaies Y. Involvement of adipose tissues in the early hypolipidemic action of PPARγ agonism in the rat. Am J Physiol Regul Integr Comp Physiol 292: R1408-R1417, 2007.
30. Lefebvre M, Paulweber B, Fajas L, Woods J, McCrary C, Colombel JF, Najib J, Fruchart JC, Datz C, Vidal H, Desreumaux P, Auwerx J. Peroxisome proliferator-activated receptor γ is induced during differentiation of colon epithelium cells. J Endocrinol 162: 331-340, 1999.
31. Li C, Dandridge KS, Di A, Marrs KL, Harris EL, Roy K, Jackson JS, Makarova NV, Fujiwara Y, Farrar PL, Nelson DJ, Tigyi GJ, Naren AP. Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions. J Exp Med 202: 975-986, 2005.
32. + conductance. Pflügers Arch 429: 517-530, 1995.
33. Lytle C, Tod TJ, Vo KT, Lee JW, Atkinson RD, Straus DS. The peroxisome proliferator-activated receptor γ ligand rosiglitazone delays the onset of inflammatory bowel disease in mice with interleukin-10 deficiency. Inflamm Bowel Dis 11: 231-243, 2005.
34. Lytle C, Xu JC, Biemesderfer D, Forbush B. Distribution and diversity of Na-K-Cl cotransport proteins: a study with monoclonal antibodies. Am J Physiol Cell Physiol 269: C1496-C1505, 1995.
35. Ma T, Thiagarajah JR, Yang H, Sonawane ND, Folli C, Galietta LJV, Verkman AS. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest 110: 1651-1658, 2002.
36. - secretion. Acta Physiol (Oxf) 189: 251-258, 2007.
37. McDaniel N, Lytle C. Parietal cells express high levels of Na-K-2Cl cotransporter on migrating into the gastric gland neck. Am J Physiol Gastrointest Liver Physiol 276: G1273-G1278, 1999.
38. Narin JG. Solutions, emulsions, suspensions and extraction. In: Remington's Pharmaceutical Sciences (18th ed.), edited by Gennaro AR. Easton, PA: Mack, 1990, p. 1632.
39. Ritz E. Edema and congestive heart failure from thiazolidone insulin sensitizers-excess sodium reabsorption in the collecting duct. J Am Soc Nephrol 16: 3139-3142, 2005.
40. Riviere PJ, Farmer SC, Burks TF, Porreca F. Prostaglandin E2-induced diarrhea in mice: importance of colonic secretion. J Pharmacol Exp Ther 256: 547-552, 1991.
41. - secretion by polarized monolayers of human colonic epithelial cells. J Clin Invest 98: 2066-2075, 1996.
42. Sarraf P, Mueller E, Jones D, King FJ, DeAngelo DJ, Partridge JB, Holden SA, Chen LB, Singer S, Fletcher C, Spiegelman BM. Differentiation and reversal of malignant changes in colon cancer through PPARγ. Nat Med 4: 1046-1052, 1998.
43. - secretion by chlorzoxazone. J Pharmacol Exp Ther 292: 778-787, 2000.
44. Song J, Knepper MA, Hu X, Verbalis JG, Ecelbarger CA. Rosiglitazone activates renal sodium- and water-reabsorptive pathways and lowers blood pressure in normal rats. J Pharmacol Exp Ther 308: 426-433, 2004.
45. Su CG, Wen X, Bailey ST, Jiang W, Rangwala SM, Keilbaugh SA, Flanigan A, Murthy S, Lazar MA, Wu GD. A novel therapy for colitis utilizing PPARγ ligands to inhibit the epithelial inflammatory response. J Clin Invest 104: 383-389, 1999.
46. Su W, Bush CR, Necela BM, Calcagno SR, Murray NR, Fields AP, Thompson EA. Differential expression, distribution, and function of PPARγ in the proximal and distal colon. Physiol Genomics 30: 342-353, 2007.
47. Thompson EA. PPARγ physiology and pathology in gastrointestinal epithelial cells. Mol Cells 24: 167-176, 2007.
48. Tontonoz P, Spiegelman BM. Fat and beyond: the diverse biology of PPARγ. Annu Rev Biochem 77: 289-312, 2008.
49. Varley CL, Southgate J. Effects of PPAR agonists on proliferation and differentiation in human urothelium. Exp Toxicol Pathol 60: 435-441, 2008.
50. Walker J, Jijon HB, Churchill T, Kulka M, Madsen KL. Activation of AMP-activated protein kinase reduces cAMP-mediated epithelial chloride secretion. Am J Physiol Gastrointest Liver Physiol 285: G850-G860, 2003.
51. Yki-Jarvinen H. Thiazolidinediones. N Engl J Med 351: 1106-1118, 2004.
52. Zhang H, Zhang A, Kohan DE, Nelson RD, Gonzales FJ, Yang T. Collecting duct-specific deletion of peroxisome proliferator-activated receptor-γ blocks thiazolidinedione-induced fluid retention. Proc Natl Acad Sci USA 102: 9406-9411, 2005.
53. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108: 1167-1174, 2001.